Localization of multidrug resistance-associated proteins along the blood-testis barrier in rat, macaque, and human testis
- PMID: 24130369
- PMCID: PMC3876786
- DOI: 10.1124/dmd.113.054577
Localization of multidrug resistance-associated proteins along the blood-testis barrier in rat, macaque, and human testis
Abstract
The blood-testis barrier (BTB) prevents the entry of many drugs into seminiferous tubules, which can be beneficial for therapy not intended for the testis but may decrease drug efficacy for medications requiring entry to the testis. Previous data have shown that some of the transporters in the multidrug resistance-associated protein (MRP) family (ABCC) are expressed in the testis. By determining the subcellular localization of these transporters, their physiologic function and effect on drug disposition may be better predicted. Using immunohistochemistry (IHC), we determined the site of expression of the MRP transporters expressed in the testis, namely, MRP1, MRP4, MRP5, and MRP8, from immature and mature rats, rhesus macaques, and adult humans. We determined that in all species MRP1 was restricted to the basolateral membrane of Sertoli cells, MRP5 is located in Leydig cells, and MRP8 is located in round spermatids, whereas MRP4 showed species-specific localization. MRP4 is expressed on the basolateral membrane of Sertoli cells in human and nonhuman primates, but on the apical membrane of Sertoli cells in immature and mature rats, representing a potential caution when using rat models as a means for studying drug disposition across the BTB. These data suggest that MRP1 may limit drug disposition into seminiferous tubules, as may MRP4 in human and nonhuman primates but not in rats. These data also suggest that MRP5 and MRP8 may not have a major impact on the penetration of drugs across the BTB.
Figures




Similar articles
-
Drug Transporters at the Human Blood-Testis Barrier.Drug Metab Dispos. 2023 May;51(5):560-571. doi: 10.1124/dmd.122.001186. Epub 2023 Feb 2. Drug Metab Dispos. 2023. PMID: 36732077 Free PMC article. Review.
-
Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier.Drug Metab Dispos. 2005 Jan;33(1):182-9. doi: 10.1124/dmd.104.001024. Epub 2004 Oct 19. Drug Metab Dispos. 2005. PMID: 15494472
-
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.Curr Med Chem. 2008;15(20):1981-2039. doi: 10.2174/092986708785132870. Curr Med Chem. 2008. PMID: 18691054 Review.
-
Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier.J Pharmacol Exp Ther. 2012 Jan;340(1):96-108. doi: 10.1124/jpet.111.186916. Epub 2011 Oct 11. J Pharmacol Exp Ther. 2012. PMID: 21990609
-
Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.J Pharmacol Exp Ther. 2017 Dec;363(3):324-335. doi: 10.1124/jpet.117.243584. Epub 2017 Sep 28. J Pharmacol Exp Ther. 2017. PMID: 28970358
Cited by
-
Drug Transporters at the Human Blood-Testis Barrier.Drug Metab Dispos. 2023 May;51(5):560-571. doi: 10.1124/dmd.122.001186. Epub 2023 Feb 2. Drug Metab Dispos. 2023. PMID: 36732077 Free PMC article. Review.
-
Generation of a hTERT-Immortalized Human Sertoli Cell Model to Study Transporter Dynamics at the Blood-Testis Barrier.Pharmaceutics. 2020 Oct 22;12(11):1005. doi: 10.3390/pharmaceutics12111005. Pharmaceutics. 2020. PMID: 33105674 Free PMC article.
-
Blood-testis barrier: a review on regulators in maintaining cell junction integrity between Sertoli cells.Cell Tissue Res. 2024 May;396(2):157-175. doi: 10.1007/s00441-024-03894-7. Epub 2024 Apr 2. Cell Tissue Res. 2024. PMID: 38564020 Review.
-
Implications of Species Differences in Function and Localization of Transporters at the Blood-Testis Barrier.Toxicol Sci. 2021 Apr 27;181(1):1-2. doi: 10.1093/toxsci/kfab024. Toxicol Sci. 2021. PMID: 33909082 Free PMC article. No abstract available.
-
In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier.Drug Metab Dispos. 2023 Sep;51(9):1157-1168. doi: 10.1124/dmd.123.001288. Epub 2023 May 31. Drug Metab Dispos. 2023. PMID: 37258305 Free PMC article. Review.
References
-
- Anderson PL, Noormohamed SE, Henry K, Brundage RC, Balfour HH, Jr, Fletcher CV. (2000) Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection. Pharmacotherapy 20:917–922 - PubMed
-
- Augustine LM, Markelewicz RJ, Jr, Boekelheide K, Cherrington NJ. (2005) Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier. Drug Metab Dispos 33:182–189 - PubMed
-
- Bart J, Hollema H, Groen HJ, de Vries EG, Hendrikse NH, Sleijfer DT, Wegman TD, Vaalburg W, van der Graaf WT. (2004) The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer 40:2064–2070 - PubMed
-
- Beringer PM, Slaughter RL. (2005) Transporters and their impact on drug disposition. Ann Pharmacother 39:1097–1108 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases